Rejuvenating immunity: "anti-aging drug today" eight years later.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

1. MRI-based multi-organ clocks for healthy aging and disease assessment.Nature medicine · 2026
   Article
2. Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics.medRxiv : the preprint server for health sciences · 2025
   Article
3. Mikhail 'Misha' Blagosklonny's enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin.Aging · 2025
   Review
4. Therapeutic Antiaging Strategies.Biomedicines · 2022
   Review
5. From causes of aging to death from COVID-19.Aging · 2020
   Review
6. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.Aging · 2020
   Review
7. Towards natural mimetics of metformin and rapamycin.Aging · 2017
   Article
8. Translational geroscience: A new paradigm for 21Translational medicine of aging · 2017
   Article
9. From rapalogs to anti-aging formula.Oncotarget · 2017
   Review
10. Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.Oncotarget · 2017
    Article
11. Immunomodulatory Activities of a Fungal Protein Extracted fromFrontiers in immunology · 2017
    Article
12. Gerosuppression by pan-mTOR inhibitors.Aging · 2016
    Article
13. Rapamycin enhances survival in a Drosophila model of mitochondrial disease.Oncotarget · 2016
    Article
14. Identification ofAging · 2016
    Article
15. Blunted dynamics of adenosine A2A receptors is associated with increased susceptibility to Candida albicans infection in the elderly.Oncotarget · 2016
    Article
16. Rapamycin in aging and disease: maximizing efficacy while minimizing side effects.Oncotarget · 2016
    Article
17. mTOR: Alzheimer's disease prevention for APOE4 carriers.Oncotarget · 2016
    Article
18. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.Aging · 2016
    Article
19. Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats.Aging · 2016
    Article
20. N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.Aging · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as